Avalon Trust’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.7M | Sell |
280,477
-3,208
| -1% | -$282K | 1.8% | 13 |
|
|
2025
Q1 | $25.9M | Buy |
283,685
+895
| +0.3% | +$81.6K | 2.06% | 12 |
|
|
2024
Q4 | $24.4M | Sell |
282,790
-5
| -0% | -$431 | 1.74% | 17 |
|
|
2024
Q3 | $26.9M | Sell |
282,795
-2,180
| -0.8% | -$207K | 1.99% | 15 |
|
|
2024
Q2 | $26.1M | Buy |
284,975
+100
| +0% | +$9.15K | 2.06% | 13 |
|
|
2024
Q1 | $25.8M | Sell |
284,875
-500
| -0.2% | -$45.4K | 2.12% | 12 |
|
|
2023
Q4 | $23.2M | Sell |
285,375
-2,200
| -0.8% | -$179K | 2.12% | 14 |
|
|
2023
Q3 | $23M | Buy |
287,575
+1,350
| +0.5% | +$108K | 2.27% | 12 |
|
|
2023
Q2 | $22.5M | Sell |
286,225
-150
| -0.1% | -$11.8K | 2.04% | 14 |
|
|
2023
Q1 | $22.2M | Buy |
+286,375
| New | +$22.2M | 2.2% | 14 |
|